clingen callow & mclean has served clients for over fifteen years with a philosophy embodied into its name; attorneys and counselors. as a relatively young firm, we practice law in a traditional way as trusted counselors to our clients. we develop long term relationships with business and individual clients and work with them to solve their legal and business problems.
Keywords to Search:
clingen callow & mclean, llc
Company Address:
2100 Manchester Rd # 1750,WHEATON,IL,USA
ZIP Code: Postal Code:
60187-4574
Telephone Number:
6308712600 (+1-630-871-2600)
Fax Number:
6308712600 (+1-630-871-2600)
Website:
www. ccmlawyer. com
Email:
USA SIC Code(Standard Industrial Classification Code):
copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
Input Form:Deal with this potential dealer,buyer,seller,supplier,manufacturer,exporter,importer
(Any information to deal,buy, sell, quote for products or service)
Welcome to ClinGen ClinGen is a National Institutes of Health (NIH)-funded resource dedicated to building a central resource that defines the clinical relevance of genes and variants for use in precision medicine and research
ENIGMA BRCA1 and BRCA2 Variant Curation Expert Panel - ClinGen . . . In discussion with members of the ClinGen SVI subgroup, approved specifications of the ACMG AMP rules for the classification of variants in the BRCA1 and BRCA2 genes are now available in the ClinGen Criteria Specification Registry
Hearing Loss Variant Curation Expert Panel - ClinGen - Clinical Genome The ClinGen Hearing Loss Expert Panel represents members at over 15 institutions across 4 continents, with a diverse array of backgrounds, including physicians (clinical geneticists, otolaryngologists, neuro-otologists,), clinical laboratory diagnosticians, and clinical and basic research scientists and genetic counselors
Low Penetrance Risk Allele - ClinGen - Clinical Genome "Recommendations for Risk Allele Evidence Curation, Classification, and Reporting from the ClinGen Low Penetrance Risk Allele Working Group" was published in December 2023